Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Position Lessened by Principal Financial Group Inc.
Principal Financial Group Inc. lowered its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,378 shares of the biopharmaceutical company’s stock after selling 230 shares during the quarter. Principal Financial Group Inc.’s holdings […]
Principal Financial Group Inc. lowered its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,378 shares of the biopharmaceutical company’s stock after selling 230 shares during the quarter. Principal Financial Group Inc.’s holdings […]
